:: RK Global ::

Company Profile

Smart Quotes

NEULAND LABORATORIES LTD.

NSE : NEULANDLABBSE : 524558ISIN CODE : INE794A01010Industry : Pharmaceuticals & DrugsHouse : Private

BSE13047.00612.75 (+4.93 %)

PREV CLOSE ( ) 12434.25

OPEN PRICE ( ) 12595.60

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 10732

TODAY'S LOW / HIGH ( )12350.00 13464.00

52 WK LOW / HIGH ( )10060 19748.4

NSE13222.00789 (+6.35 %)

PREV CLOSE( ) 12433.00

OPEN PRICE ( ) 12587.00

BID PRICE (QTY) 13222.00 (44)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 161018

TODAY'S LOW / HIGH( ) 12349.00 13480.00

52 WK LOW / HIGH ( )10400.15 19747

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 07-01 1984

Management Info

Davuluri Rama Mohan Rao - Chairman Davuluri Saharsh Rao - Managing Director

Registered Office

Address 11th Floor (5th Office Level),Phoenix I V Y Building, Plot No.573 A- I I I,Road No. 82, Jubilee Hills,
Hyderabad,
Telangana-500033

Phone 040-67611600 / 67611700

Email neuland@neulandlabs.com

Website www.neulandlabs.com

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

11Mar Neuland Laboratories informs about new
Pursuant to Regulation 47 of the Securities and Exchange Board of India..

04Feb Neuland Laboratories informs about ana
Neuland Laboratories has informed that the Company’s management will be..

27Jan Neuland Laboratories informs about ana
Neuland Laboratories has informed that the company will announce its res..

19Dec Neuland Laboratories informs about new
Pursuant to Regulation 47 of the Securities and Exchange Board of India..

15Dec Neuland Laboratories informs about an
Neuland Laboratories has informed that the Company’s management will be..

Financials

in Crores

	QTR Dec 25	ANNUAL 25
Net Profit	40.42	259.43
Gross Profit	54.27	345.37
Operating Profit	84.98	342.81
Net Sales	439.71	1476.84

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Sanofi Cons. Health (BSE) 4676.15 (2.33%)	M.Cap ( in Cr)10769.46
Acutaas Chemicals (BSE) 2214.90 (4.92%)	M.Cap ( in Cr)18133.63
NGL Fine-Chem (BSE) 2240.65 (4.38%)	M.Cap ( in Cr)1384.28
Sanofi India (BSE) 3332.00 (2.05%)	M.Cap ( in Cr)7673.80
Glaxosmithkline Phar (BSE) 2347.00 (1.58%)	M.Cap ( in Cr)39759.60

Shareholding Pattern

	PROMOTERS	32.63%
	NON-INSTITUTION	31.76%
	MUTUAL FUNDS/UTI	10.39%
	FI/BANKS/INSURANCE	1.18%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
LIC MF Healthcare Fund-Reg(G)	4.12
Bajaj Finserv Healthcare Fund-Reg(G)	2.78
ITI Pharma & Healthcare Fund-Reg(G)	2.08
PGIM India Healthcare Fund-Reg(G)	1.82
HSBC Focused Fund-Reg(G)	1.74
Tata Nifty MidSmall Healthcare Index Fund-Reg(G)	1.74
Motilal Oswal Nifty MidSmall Healthcare Index Fund-Reg(G)	1.73

Call Us +91 -33 40142930

Email Us care.kolkata@rkglobal.in

Corporate Office Flat No.5 Sagar Apartment 6 Tilak Marg, New Delhi 110 001

Attention Investors

Prevent unauthorised Transactions in your account —> Update your mobile numbers/email 10s with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day ...... Issued in the interest of Investors Prevent Unauthorized Transactions in your demat account—> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day Issued in the interest of investors. No need to issue cheques by investor while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of

KYC

KYC KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DR Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Compliance Officer : Mr. Kamesh Gupta. 011-43100999. kgupta@rkglobal.in / grievances@rkglobal.in - File a Complaint on SCORES

Registration Nos : SEBI Registration No . INZ000187132; Research Regn. No. : INH000002210; IN-DP-241-2016; NSDL: DP ID - IN 302453 (Delhi), IN 302951 (Kolkata); R K Global Shares & Securities Ltd CIN NO:U99999MH1995PTC174185;

Filing Complaints on SCORES - Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, Email ID. Benefits: Effective Communication, Speedy redressal of the grievances.

Company

Quick LInks

Designed,Developed & Content Powered by Accord Fintech Pvt Ltd.